The board of directors of China Resources Pharmaceutical Group Limited announced, with effect from 29 May 2019: Mr. LI Xiangming has been appointed as an executive director and a member of the executive committee of the Company; and Mr. QIU Huawei has been appointed as an executive director and a member of the executive committee of the Company. Mr. LI Xiangming, aged 54, was appointed as the chairman of China Resources Pharmaceutical Commercial Group Company Limited ("CR Pharmaceutical Commercial") (a wholly owned subsidiary of the Company) in February 2019. Mr. LI currently holds various internal positions including the chairman of CR Guangdong Pharmaceutical Co. Ltd. He also serves as a vice president of China Association of Pharmaceutical Commerce and a chief supervisor of Beijing Pharmaceutical Association. Mr. QIU Huawei, aged 52, is a director and a president of China Resources Sanjiu Medical & Pharmaceutical Company Limited. The Board announces, with effect from 29 May 2019: Mr. CHEN Rong ("Mr. CHEN") has resigned as a non-executive director and a member of the audit committee and remuneration committee of the Company due to his other work arrangement; and Ms. GUO Wei ("Ms. GUO") has been appointed as a non-executive director and a member of the audit committee and remuneration committee of the Company. Ms. GUO Wei, aged 43, was appointed as a deputy financial director of the Finance Department of China Resources (Holdings) Company Limited in April 2017. Ms. GUO has been a director of China Resources Double-Crane Pharmaceutical Company Limited.